Scott Moore explores China’s trajectory in the global biotechnology sector. While The us continues to be the dominant worldwide participant in developing and commercializing biotechnology for many years, China is determined to be a number one player in biotechnology and is also investing greatly while in the sector. Moore argues that, while the U